IN163229B - - Google Patents
Info
- Publication number
- IN163229B IN163229B IN234/CAL/85A IN234CA1985A IN163229B IN 163229 B IN163229 B IN 163229B IN 234CA1985 A IN234CA1985 A IN 234CA1985A IN 163229 B IN163229 B IN 163229B
- Authority
- IN
- India
- Prior art keywords
- marek
- disease
- virus
- mdv
- monovalent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8401120A NL8401120A (nl) | 1984-04-09 | 1984-04-09 | Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek. |
| PCT/NL1985/000014 WO1985004588A1 (en) | 1984-04-09 | 1985-03-27 | Live purified marek's disease vaccine and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN163229B true IN163229B (es) | 1988-08-27 |
Family
ID=19843774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN234/CAL/85A IN163229B (es) | 1984-04-09 | 1985-03-28 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4673572A (es) |
| EP (1) | EP0159743B1 (es) |
| JP (1) | JPS6123A (es) |
| AT (1) | ATE56364T1 (es) |
| AU (1) | AU574164B2 (es) |
| CA (1) | CA1251397A (es) |
| DD (1) | DD232822A5 (es) |
| DE (1) | DE3579617D1 (es) |
| ES (1) | ES8605680A1 (es) |
| HU (1) | HU194496B (es) |
| IL (1) | IL74809A (es) |
| IN (1) | IN163229B (es) |
| MX (1) | MX7718E (es) |
| NL (1) | NL8401120A (es) |
| WO (1) | WO1985004588A1 (es) |
| YU (1) | YU44687B (es) |
| ZA (1) | ZA852564B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456101A (en) * | 1980-11-08 | 1984-06-26 | Honda Giken Kogyo Kabushiki Kaisha | Vehicular brake operating system |
| JP2508625B2 (ja) * | 1985-08-30 | 1996-06-19 | ソニー株式会社 | 半導体レ−ザ− |
| FR2598596B1 (fr) * | 1986-05-15 | 1990-10-19 | Sanofi Elf Bio Ind | Procede de traitement du lait en vue de l'obtention de fromages |
| US5849299A (en) * | 1991-06-28 | 1998-12-15 | The United States Of America As Represented By The Secretary Of Agriculture | Attenuated revertant serotype 1 marek's disease vaccine |
| WO1993023078A1 (en) * | 1992-05-19 | 1993-11-25 | Viktoria Alexeevna Lukina | Vaccine for prophylaxis of marek disease of birds and method of its preparation |
| EP0703294A1 (en) * | 1994-07-14 | 1996-03-27 | Akzo Nobel N.V. | Marek's disease virus vaccine |
| IL114501A (en) * | 1994-07-14 | 1999-08-17 | Akzo Nobel Nv | Marek's disease virus vaccine |
| EP0748867A1 (en) * | 1995-06-12 | 1996-12-18 | Duphar International Research B.V | Marek's disease vaccine |
| US5989805A (en) * | 1995-10-27 | 1999-11-23 | Board Of Trustees Operating Michigan State University | Immortal avian cell line to grow avian and animal viruses to produce vaccines |
| WO1997046103A1 (en) * | 1996-06-04 | 1997-12-11 | University Of Georgia Research Foundation, Inc. | Modified live avian polyomavirus vaccine in psittacine birds |
| EP1038952A3 (en) * | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
| JP2015512396A (ja) | 2012-03-22 | 2015-04-27 | メリアル リミテッド | 改変マレック病ウイルス及び前記ウイルスから作製されるワクチン |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1292803A (en) * | 1968-11-18 | 1972-10-11 | Nat Res Dev | Improvements relating to the production of antigens |
| US3642574A (en) * | 1970-04-29 | 1972-02-15 | Us Agriculture | Method for producing vaccine for immunization of poultry against marek{3 s disease |
| US3783098A (en) * | 1971-08-10 | 1974-01-01 | Cornell Res Foundation Inc | Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same |
| US4160024A (en) * | 1978-05-01 | 1979-07-03 | Cornell Research Foundation, Inc. | Marek's disease vaccine |
-
1984
- 1984-04-09 NL NL8401120A patent/NL8401120A/nl not_active Application Discontinuation
-
1985
- 1985-03-25 AT AT85200461T patent/ATE56364T1/de not_active IP Right Cessation
- 1985-03-25 EP EP85200461A patent/EP0159743B1/en not_active Expired - Lifetime
- 1985-03-25 DE DE8585200461T patent/DE3579617D1/de not_active Expired - Lifetime
- 1985-03-27 AU AU41561/85A patent/AU574164B2/en not_active Ceased
- 1985-03-27 WO PCT/NL1985/000014 patent/WO1985004588A1/en unknown
- 1985-03-27 HU HU851448A patent/HU194496B/hu not_active IP Right Cessation
- 1985-03-28 IN IN234/CAL/85A patent/IN163229B/en unknown
- 1985-04-03 IL IL74809A patent/IL74809A/xx not_active IP Right Cessation
- 1985-04-03 ES ES541930A patent/ES8605680A1/es not_active Expired
- 1985-04-04 ZA ZA852564A patent/ZA852564B/xx unknown
- 1985-04-05 US US06/720,176 patent/US4673572A/en not_active Expired - Lifetime
- 1985-04-08 MX MX851025U patent/MX7718E/es unknown
- 1985-04-08 DD DD85274954A patent/DD232822A5/de not_active IP Right Cessation
- 1985-04-09 CA CA000478672A patent/CA1251397A/en not_active Expired
- 1985-04-09 JP JP60075246A patent/JPS6123A/ja active Granted
- 1985-04-09 YU YU599/85A patent/YU44687B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX7718E (es) | 1990-10-10 |
| ES8605680A1 (es) | 1986-04-16 |
| DD232822A5 (de) | 1986-02-12 |
| AU4156185A (en) | 1985-11-01 |
| JPS6123A (ja) | 1986-01-06 |
| ZA852564B (en) | 1985-11-27 |
| DE3579617D1 (de) | 1990-10-18 |
| US4673572A (en) | 1987-06-16 |
| EP0159743A1 (en) | 1985-10-30 |
| IL74809A (en) | 1990-09-17 |
| EP0159743B1 (en) | 1990-09-12 |
| CA1251397A (en) | 1989-03-21 |
| ATE56364T1 (de) | 1990-09-15 |
| AU574164B2 (en) | 1988-06-30 |
| IL74809A0 (en) | 1985-07-31 |
| JPH0317808B2 (es) | 1991-03-11 |
| ES541930A0 (es) | 1986-04-16 |
| NL8401120A (nl) | 1985-11-01 |
| YU59985A (en) | 1988-06-30 |
| WO1985004588A1 (en) | 1985-10-24 |
| HUT38542A (en) | 1986-06-30 |
| YU44687B (en) | 1990-12-31 |
| HU194496B (en) | 1988-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA852564B (en) | Live purified marek's disease vaccine | |
| EP0125245B1 (en) | Propagation of hemorrhagic enteritis virus in a turkey cell line | |
| ALLEN et al. | Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity | |
| ES8200227A1 (es) | Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral | |
| EP0775743A2 (en) | Sustainable chick cell line infected with Marek's disease virus | |
| CA1292689C (en) | Live vaccine for contagious disease of chickens | |
| US5686287A (en) | Marek's disease virus vaccine | |
| CA2222482A1 (en) | Non-virulent mycoplasma synoviae and vaccine thereof | |
| US4895718A (en) | Serotype 2 Marek's disease vaccine | |
| US5149530A (en) | Live newcastle disease virus vaccines | |
| HU914111D0 (en) | Cell-less marek-type virus vaccine | |
| Carmichael et al. | Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups | |
| CA2112225C (en) | Attenuated revertant serotype 1 marek's disease vaccine | |
| US4213965A (en) | Small-plaque variant canine herpesvirus vaccine | |
| US5565202A (en) | Low enhancement serotype 2 vaccine for marek's disease | |
| Eisenstein et al. | Salmonella vaccines: Protection by endotoxin protein and lipopolysaccharide in two different mouse strains. | |
| ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
| Jeffries et al. | Atypical menaquinone pattern in a strain of Staphylococcus aureus | |
| EP0703294A1 (en) | Marek's disease virus vaccine | |
| CA1289881C (en) | Vaccine against herpes simplex | |
| KR960016906A (ko) | 약독화 수두 생바이러스 백신 및 그의 제조방법 | |
| RO96364B1 (ro) | PROCEDEU DE PREPARARE A UNUI VACCIN VIU PURIFICAT îMPOTRIVA BOLII LUI MAREK |